doctor
WikiMD is world's largest health encyclopedia with
28,597 pages, 3,995,032 edits & 34,400,011 views.
Abexinostat
Jump to navigation
Jump to search
Join WikiMD as a freelancer or paid editor and help improve the page Abexinostat or others.
Abexinostat (INN,[1] formerly PCI-24781) is an experimental drug candidate for cancer treatment.[2] It was developed by Pharmacyclics and licensed to Xynomic. and is in Phase II clinical trials for B-cell lymphoma.[3] Pre-clinical study suggests the potential for treatment of different types of cancer as well.[4][5][6][7]
Abexinostat exerts its effect as a pan-histone deacetylase inhibitor[8][9] and inhibits RAD51, which is involved in repairing DNA double strand breaks.[10]
References
- ↑ WHO Drug Information, Vol. 25, No. 2, 2011
- ↑ Abexinostat, NCI Cancer Dictionary
- ↑ Abexinostat HCl (PCI-24781), PanHDAC-inhibitor Archived 2013-10-27 at the Wayback Machine, Pharmacyclics
- ↑
- ↑
- ↑
- ↑
- ↑
- ↑
- ↑
edit
WikiMD Resources - Abexinostat
Latest research (Pubmed)
Resources for Abexinostat | |
| Uptodate | |
| Medline | |
| About | |
Social media links on Abexinostat
  | |
| Abexinostat is part of WikiMD's Physician reviewed^ articles available 4free, 4all, 4ever! |
|---|
| Medicine: Health - Encyclopedia - Topics - Diseases - Cancer - Rare diseases - Random Page Navigation: Drugs - Wellness - Obesity - Diet - Ketogenic diet - W8MD weight loss diet - Editors: Recently Edited Pages - Alphabetical Order - Sponsors - USMLE The content on or accessible through WikiMD is for informational purposes only. WikiMD is not a substitute for professional medical advice. ^See full Disclaimers |
 Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP* |
